BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10341290)

  • 1. Receptor-mediated interleukin-2 gene transfer into human hepatoma cells.
    Junbo H; Li Q; Zaide W; Yunde H
    Int J Mol Med; 1999 Jun; 3(6):601-8. PubMed ID: 10341290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylated histone-mediated gene transfer and expression.
    Chen J; Stickles RJ; Daichendt KA
    Hum Gene Ther; 1994 Apr; 5(4):429-35. PubMed ID: 8049301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).
    Sun X; Hai L; Wu Y; Hu HY; Zhang ZR
    J Drug Target; 2005 Feb; 13(2):121-8. PubMed ID: 15823963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
    Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
    Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells.
    Han J; Il Yeom Y
    Int J Pharm; 2000 Jul; 202(1-2):151-60. PubMed ID: 10915938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of retroviral vectors to induce strong hepatoma cell-specific expression of cytokine genes.
    Cao G; Kuriyama S; Du P; Sakamoto T; Yang W; Masui K; Qi Z
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1053-61. PubMed ID: 8985830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
    Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
    J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
    Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
    Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates.
    Kim TG; Kang SY; Kang JH; Cho MY; Kim JI; Kim SH; Kim JS
    Bioconjug Chem; 2004; 15(2):326-32. PubMed ID: 15025528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor.
    Mkhwanazi NK; de Koning CB; van Otterlo WAL; Ariatti M; Singh M
    Z Naturforsch C J Biosci; 2017 Jul; 72(7-8):293-301. PubMed ID: 28063265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells.
    He P; Tang ZY; Ye SL; Liu BB; Liu YK
    J Exp Clin Cancer Res; 2000 Jun; 19(2):183-7. PubMed ID: 10965816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid.
    Singh M; Kisoon N; Ariatti M
    Drug Deliv; 2001; 8(1):29-34. PubMed ID: 11280441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo transfection of hepatitis C virus complementary DNA into rodent liver by asialoglycoprotein receptor mediated gene delivery.
    Yamamoto M; Hayashi N; Miyamoto Y; Takehara T; Mita E; Seki M; Fusamoto H; Kamada T
    Hepatology; 1995 Sep; 22(3):847-55. PubMed ID: 7657292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes.
    Han J; Lim M; Yeom YI
    Biol Pharm Bull; 1999 Aug; 22(8):836-40. PubMed ID: 10480322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
    Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
    Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
    Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
    J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
    Díez S; Navarro G; de ILarduya CT
    J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.